33rd week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200253907 | Compositions and Methods for Treating Neurodegenerative Diseases | 2020-08-13 |
20200253908 | USE OF AMINO ACID SUPPLEMENTATION FOR IMPROVED MUSCLE PROTEIN SYNTHESIS | 2020-08-13 |
20200253909 | RACEMIC BETA-HYDROXYBUTYRATE MIXED SALT-ACID COMPOSITIONS AND METHODS OF USE | 2020-08-13 |
20200253910 | METHOD FOR INCREASING SERUM ADIPONECTIN FOR TREATMENT AND REDUCTION OF THE RISK OF CARDIOVASCULAR, VASCULAR, AND RELATED DISEASES | 2020-08-13 |
20200253911 | METHOD OF TREATING RENAL SYSTEM DAMAGE | 2020-08-13 |
20200253912 | Modulators of Prostate-Specific G-Protein Receptor (PSGR/OR51E2) and Methods of Using Same | 2020-08-13 |
20200253913 | COMPOSITIONS FOR INHIBITING 3' REPAIR EXONUCLEASE 2 AND METHODS OF SCREENING FOR SUCH COMPOSITIONS | 2020-08-13 |
20200253914 | NOVEL FORMULATIONS | 2020-08-13 |
20200253915 | METHOD OF PREVENTING OR TREATING SIDE EFFECT OF TUMOR THERAPY | 2020-08-13 |
20200253916 | Compositions of Azadirachta Indica and Methods of Treating Cancer | 2020-08-13 |
20200253917 | COMPOSITIONS AND METHODS FOR MODULATING HAIR GROWTH | 2020-08-13 |
20200253918 | THERAPEUTIC AGENTS CONTAINING CANNABIS FLAVONOID DERIVATIVES TARGETING KINASES, SIRTUINS AND ONCOGENIC AGENTS FOR THE TREATMENT OF CANCERS | 2020-08-13 |
20200253919 | TERPENE-ENRICHED CANNABINOID PRODUCT FOR WOMEN HEALTH | 2020-08-13 |
20200253920 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY | 2020-08-13 |
20200253921 | Cannabinoid Formulations | 2020-08-13 |
20200253922 | METHODS FOR NON-IRRITATING PULMONARY ADMINISTRATION OF CANNABINOIDS USING SOFT MIST INHALERS | 2020-08-13 |
20200253923 | NEW CANNABIS COMPOSITIONS AND INDUSTRIAL METHODS FOR PRODUCTION THEREOF | 2020-08-13 |
20200253924 | WATER SOLUBLE COMPOSITIONS COMPRISING PURIFIED CANNABINOIDS | 2020-08-13 |
20200253925 | GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS | 2020-08-13 |
20200253926 | THERAPEUTIC COMBINATIONS | 2020-08-13 |
20200253927 | USES OF INDOLINONE COMPOUNDS | 2020-08-13 |
20200253928 | COMPOSITION FOR DECREASING SERUM URIC ACID LEVEL | 2020-08-13 |
20200253929 | TREATMENT OF EPILEPSY | 2020-08-13 |
20200253930 | 3-(5-Fluoroindolyl)-4-arylmaleimide Compounds and their Use in Tumor Treatment | 2020-08-13 |
20200253931 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRESBYOPIA, MYDRIASIS, AND OTHER OCULAR DISORDERS | 2020-08-13 |
20200253932 | TARGETED EPIGENETIC THERAPY FOR INHERITED AORTIC ANEURYSM CONDITION | 2020-08-13 |
20200253933 | METHODS FOR TREATING DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME | 2020-08-13 |
20200253934 | INHIBITORS OF PDE6DELTA FOR USE IN THE PREVENTION AND/OR TREATMENT OF EPILEPSY AND/OR NEURODEGENERATIVE DISORDERS | 2020-08-13 |
20200253935 | Ifetroban Treatment for Systemic Sclerosis | 2020-08-13 |
20200253936 | HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE | 2020-08-13 |
20200253937 | 5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | 2020-08-13 |
20200253938 | Extended Release Methazolamide Formulation | 2020-08-13 |
20200253939 | ACTIVATING PYRUVATE KINASE R | 2020-08-13 |
20200253940 | DHODH INHIBITOR FOR USE IN TREATING HEMATOLOGIC CANCERS | 2020-08-13 |
20200253941 | PHARMACEUTICAL COMPOSITIONS | 2020-08-13 |
20200253942 | THERAPEUTIC DRUG FOR ECTOPIC OSSIFICATION HAVING MECHANISM TO INHIBIT PAR1 | 2020-08-13 |
20200253943 | TRPV2 Antagonists | 2020-08-13 |
20200253944 | TOPICAL SEMISOLID COMPOSITION CONTAINING AN ANTIMICROBIAL AGENT AND PIRFENIDONE FOR THE TREATMENT OF CHRONIC SKIN DAMAGE | 2020-08-13 |
20200253945 | DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USING THE SAME | 2020-08-13 |
20200253946 | DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF PANTOPRAZOLE AND PROCESS FOR FORMULATION THEREOF | 2020-08-13 |
20200253947 | CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT | 2020-08-13 |
20200253948 | CANNABINOID RECEPTOR AGONISTS AND SERINE HYDROLASE ENZYME INHIBITOR BASED ANXIOLYTIC THERAPEUTIC PRODUCT | 2020-08-13 |
20200253949 | PIPERIDINYL-PROPANONE DERIVATIVES | 2020-08-13 |
20200253950 | Pharmaceutical Formulations Comprising CCR3 Antagonists | 2020-08-13 |
20200253951 | COMBINATION OF AN ANTIALLERGIC AGENT WITH MUSCARINIC ANTAGONIST AND/OR DOPAMINERGIC AGONIST FOR USE IN PREVENTING/STOPPING OF AXIAL MYOPIA IN HUMAN | 2020-08-13 |
20200253952 | Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 | 2020-08-13 |
20200253953 | COMPOSITIONS OF CXCR4 INHIBITORS AND METHODS OF PREPARATION AND USE | 2020-08-13 |
20200253954 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | 2020-08-13 |
20200253955 | Naloxegol Oxalate and Solid Dispersion thereof | 2020-08-13 |
20200253956 | PHARMACEUTICAL RESINATE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF | 2020-08-13 |
20200253957 | TRANSDERMAL DELIVERY SYSTEM | 2020-08-13 |
20200253958 | PHENYLPIPERAZINE PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) MODULATORS AND THEIR USE | 2020-08-13 |
20200253959 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES | 2020-08-13 |
20200253960 | ANTIBIOTIC FORMULATIONS FOR TREATING OF CAVITY INFECTIONS | 2020-08-13 |
20200253961 | AMINE SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF | 2020-08-13 |
20200253962 | TREATMENT OF VASOMOTOR SYMPTOMS | 2020-08-13 |
20200253963 | COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A SELECTIVE BCL-2 INHIBITOR | 2020-08-13 |
20200253964 | ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF | 2020-08-13 |
20200253965 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | 2020-08-13 |
20200253966 | CRAC CHANNEL INHIBITOR COMPOSITIONS | 2020-08-13 |
20200253967 | NOVEL COMPOUNDS | 2020-08-13 |
20200253968 | Solid Pharmaceutical Compositions for Treating HCV | 2020-08-13 |
20200253969 | PYRAZOLO[3,4-B]PYRAZINE DERIVATIVES AS SHP2 PHOSPHATASE INHIBITORS | 2020-08-13 |
20200253970 | Method of Treating Metabolic Disorders and Depression with Dopamine Receptor Agonists | 2020-08-13 |
20200253971 | DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF | 2020-08-13 |
20200253972 | CRYSTAL FORM OF OREXIN RECEPTOR ANTAGONIST COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | 2020-08-13 |
20200253973 | METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS | 2020-08-13 |
20200253974 | QUINAZOLINE COMPOUNDS AS MODULATORS OF RAS SIGNALING | 2020-08-13 |
20200253975 | EXON 18 AND/OR EXON 21 MUTANT EGFR SELECTIVE INHIBITOR | 2020-08-13 |
20200253976 | Endothelial Facilitation in Neurodegerative Diseases by Cerebral Blood Flow Enhancement | 2020-08-13 |
20200253977 | METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | 2020-08-13 |
20200253978 | HETEROCYCLICS AS INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR | 2020-08-13 |
20200253979 | THERAPEUTIC METHODS RELATING TO HSP90 INHIBITORS | 2020-08-13 |
20200253980 | COMBINATION OF PI3K INHIBITOR AND C-MET INHIBITOR | 2020-08-13 |
20200253981 | USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS | 2020-08-13 |
20200253982 | MUSCARINIC M1 RECEPTOR AGONISTS | 2020-08-13 |
20200253983 | ORALLY INHALED AND NASAL BENZODIAZEPINES | 2020-08-13 |
20200253984 | Methods of Reducing Mammographic Breast Density and/or Breast Cancer Risk | 2020-08-13 |
20200253985 | NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF | 2020-08-13 |
20200253986 | TRIPTONIDE OR A COMPOSITION COMPRISING TRIPTONIDE FOR USE IN TREATING DISORDERS | 2020-08-13 |
20200253987 | Method of Treating and Preventing Secondary Hyperparathyroidism | 2020-08-13 |
20200253988 | ADJUNCTIVE THERAPY WITH 25-HYDROXYVITAMIN D | 2020-08-13 |
20200253989 | Scalable Vitamin Composition Unit Dosage for the Treatment of Fat-Soluble Vitamin Deficiencies | 2020-08-13 |
20200253990 | ASPIRIN FORMULATION FOR INCREASED EFFICACY | 2020-08-13 |
20200253991 | Methods of Inhibiting Pathological Angiogenesis | 2020-08-13 |
20200253992 | Methods of Identifying Novel Dosing Regimens | 2020-08-13 |
20200253993 | NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2020-08-13 |
20200253994 | PYRIMIDINE DERIVATIVE CONTAINING COMPOSITIONS | 2020-08-13 |
20200253995 | METHOD TO TREAT HYPERCHOLESTEROLEMIA BY MODULATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN ACTIVITY WITH SMALL MOLECULE LIGANDS | 2020-08-13 |
20200253996 | TCTP INHIBITING AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES, INFECTIOUS DISEASES, ALLERGIES, INFLAMMATIONS AND/OR ASTHMA | 2020-08-13 |
20200253997 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | 2020-08-13 |
20200253998 | Compositions And Methods For Immunotherapy | 2020-08-13 |
20200253999 | NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML) | 2020-08-13 |
20200254000 | THERAPEUTIC AGENT FOR DRY EYE CHARACTERIZED BY BEING APPLIED TO EYE OF DRY EYE PATIENT WEARING SOFT CONTACT LENS | 2020-08-13 |
20200254001 | THERAPEUTIC PHARMACEUTICAL COMPOSITION FOR CANCER INCLUDING MIRNA | 2020-08-13 |
20200254002 | COMBINATION THERAPIES FOR TREATING MUSCULAR DYSTROPHY | 2020-08-13 |
20200254003 | OLIGOSACCHARIDE COMPOUND FOR INHIBITING INTRINSIC COAGULATION FACTOR X-ENZYME COMPLEX, AND PREPARATION METHOD THEREFOR AND USES THEREOF | 2020-08-13 |
20200254004 | BIOCOMPATIBLE MATERIAL AND METHODS FOR MAKING AND USING THEREOF | 2020-08-13 |
20200254005 | Application of Low-Molecular-Weight Hyaluronic Acid (LMW-HA) Fragments | 2020-08-13 |
20200254006 | METHODS AND COMPOSITIONS FOR EXTENDING LIFESPAN | 2020-08-13 |